220 related articles for article (PubMed ID: 33887244)
1. Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure.
Griffith DE; Thomson R; Flume PA; Aksamit TR; Field SK; Addrizzo-Harris DJ; Morimoto K; Hoefsloot W; Mange KC; Yuen DW; Ciesielska M; Wallace RJ; van Ingen J; Brown-Elliott BA; Coulter C; Winthrop KL;
Chest; 2021 Sep; 160(3):831-842. PubMed ID: 33887244
[TBL] [Abstract][Full Text] [Related]
2. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by
Griffith DE; Eagle G; Thomson R; Aksamit TR; Hasegawa N; Morimoto K; Addrizzo-Harris DJ; O'Donnell AE; Marras TK; Flume PA; Loebinger MR; Morgan L; Codecasa LR; Hill AT; Ruoss SJ; Yim JJ; Ringshausen FC; Field SK; Philley JV; Wallace RJ; van Ingen J; Coulter C; Nezamis J; Winthrop KL;
Am J Respir Crit Care Med; 2018 Dec; 198(12):1559-1569. PubMed ID: 30216086
[No Abstract] [Full Text] [Related]
3. Amikacin Liposome Inhalation Suspension for
Winthrop KL; Flume PA; Thomson R; Mange KC; Yuen DW; Ciesielska M; Morimoto K; Ruoss SJ; Codecasa LR; Yim JJ; Marras TK; van Ingen J; Wallace RJ; Brown-Elliott BA; Coulter C; Griffith DE
Ann Am Thorac Soc; 2021 Jul; 18(7):1147-1157. PubMed ID: 33326356
[No Abstract] [Full Text] [Related]
4. Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study.
Morimoto K; Nonaka M; Yamazaki Y; Nakagawa T; Takasaki J; Tsuyuguchi K; Kitada S; Jumadilova Z; Yuen DW; Ciesielska M; Hasegawa N
Respir Investig; 2024 Mar; 62(2):284-290. PubMed ID: 38277865
[TBL] [Abstract][Full Text] [Related]
5. Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use.
Hoy SM
Clin Drug Investig; 2021 Apr; 41(4):405-412. PubMed ID: 33723805
[TBL] [Abstract][Full Text] [Related]
6. Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease.
Shirley M
Drugs; 2019 Apr; 79(5):555-562. PubMed ID: 30877642
[TBL] [Abstract][Full Text] [Related]
7. Amikacin Liposome Inhalation Suspension for
Golia A; Mahmood BR; Fundora Y; Thornby KA; Chahine EB
Sr Care Pharm; 2020 Apr; 35(4):162-170. PubMed ID: 32192565
[No Abstract] [Full Text] [Related]
8. Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease.
Rubino CM; Onufrak NJ; van Ingen J; Griffith DE; Bhavnani SM; Yuen DW; Mange KC; Winthrop KL
Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):277-287. PubMed ID: 33595792
[TBL] [Abstract][Full Text] [Related]
9. Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease.
Siegel SAR; Griffith DE; Philley JV; Brown-Elliott BA; Brunton AE; Sullivan PE; Fuss C; Strnad L; Wallace RJ; Winthrop KL
Chest; 2023 Oct; 164(4):846-859. PubMed ID: 37419144
[TBL] [Abstract][Full Text] [Related]
10. Amikacin liposome inhalation suspension as a treatment for patients with refractory mycobacterium avium complex lung infection.
Zhang Y; Hill AT
Expert Rev Respir Med; 2021 Jun; 15(6):737-744. PubMed ID: 34039231
[No Abstract] [Full Text] [Related]
11. A case of drug-induced organizing pneumonia caused by amikacin liposome inhalation suspension.
Takao D; Takeda K; Takazono T; Ozasa M; Ito Y; Ashizawa N; Hirayama T; Iwanaga N; Takemoto S; Ide S; Tashiro M; Hosogaya N; Kido T; Sakamoto N; Obase Y; Okano S; Izumikawa K; Yanagihara K; Mukae H
J Infect Chemother; 2023 Aug; 29(8):806-808. PubMed ID: 37098378
[TBL] [Abstract][Full Text] [Related]
12. The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults.
Khan O; Chaudary N
Drug Des Devel Ther; 2020; 14():2287-2294. PubMed ID: 32606598
[TBL] [Abstract][Full Text] [Related]
13. Laryngeal Injury Due to Amikacin Inhalation for Refractory Mycobacterium avium Complex Infection.
Axiotakis LG; Enver N; Keating CL; Pitman MJ
Chest; 2021 Apr; 159(4):e185-e187. PubMed ID: 34022015
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management.
Daley CL; Winthrop KL
J Infect Dis; 2020 Aug; 222(Suppl 4):S199-S211. PubMed ID: 32814943
[TBL] [Abstract][Full Text] [Related]
15. Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory
Morita A; Namkoong H; Yagi K; Asakura T; Hosoya M; Tanaka H; Lee H; Ogawa T; Kusumoto T; Azekawa S; Nakagawara K; Kamata H; Ishii M; Fukunaga K; Ozawa H; Hasegawa N
Infect Drug Resist; 2022; 15():4001-4011. PubMed ID: 35924016
[TBL] [Abstract][Full Text] [Related]
16. Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease.
Griffith DE; Adjemian J; Brown-Elliott BA; Philley JV; Prevots DR; Gaston C; Olivier KN; Wallace RJ
Am J Respir Crit Care Med; 2015 Sep; 192(6):754-60. PubMed ID: 26068042
[TBL] [Abstract][Full Text] [Related]
17. Amikacin liposome and Mycobacterium avium complex: A systematic review.
Zangiabadian M; Malekshahian D; Arabpour E; Abadi SSD; Yazarlou F; Bostanghadiri N; Centis R; Aghababa AA; Farahbakhsh M; Nasiri MJ; Sotgiu G; Migliori GB
PLoS One; 2022; 17(12):e0279714. PubMed ID: 36574432
[TBL] [Abstract][Full Text] [Related]
18. Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease.
Jhun BW; Yang B; Moon SM; Lee H; Park HY; Jeon K; Kwon OJ; Ahn J; Moon IJ; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661870
[TBL] [Abstract][Full Text] [Related]
19. Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings.
Aksamit T; Wu J; Hassan M; Achter E; Chatterjee A
BMC Pulm Med; 2022 Dec; 22(1):461. PubMed ID: 36463137
[TBL] [Abstract][Full Text] [Related]
20. Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion.
Mingora CM; Garcia BA; Mange KC; Yuen DW; Ciesielska M; van Ingen J; Flume PA; Dorman SE
BMC Infect Dis; 2022 Mar; 22(1):246. PubMed ID: 35279081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
